EUVIMEDEUVIMED entdecken
Crossref

Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro

A S Gorbunov, A V Mukhomedzyanov, S V Popov, V N Azev, L N Maslov

Bulletin of Experimental Biology and Medicine · 2024-11 · 178 (1) · 86-90

DOI: 10.1007/s10517-024-06287-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Experimental Biology and Medicine, online erschienen am 22.11.2024. Verfasst von A S Gorbunov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russia. Hauptthemen laut MEDLINE: Rats, Wistar, Myocardial Reperfusion Injury, Receptors, Opioid, mu, Oligopeptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effect of the selective μ2-opioid receptor agonist endomorphin-1 in reperfusion injury in male Wistar rats was studied in vivo and in vitro. The in vivo experiment included coronary artery occlusion (45 min) and reperfusion (120 min); in in vitro experiments, 45-min global ischemia of the isolated rat heart was followed by 30-min reperfusion. Endomorphin-1 was administered intravenously 5 min before in vivo reperfusion (at a dose 50 μg/kg) or added to the perfusion solution at the onset of reperfusion of the isolated heart (in a concentration of 152 nmol/liter). In vivo endomorphin-1 reduced the infarct size by 33% compared to the control group. In experiments on isolated heart, endomorphin-1 improved the contractile function during reperfusion and reduced the creatine kinase level in the coronary effluent. Hence, stimulation of cardiac μ2-opioid receptors increases heart tolerance to the pathogenic effects of reperfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, WistarMyocardial Reperfusion InjuryReceptors, Opioid, muOligopeptidesAnimalsMaleRatsCardiotonic AgentsMyocardial InfarctionCreatine KinaseMyocardiumHeartMyocardial Contraction

Stichwörter der Autor:innen

cardioprotective effectheartischemia/reperfusionopioid peptidesopioid receptors

Substanzen

endomorphin 1Receptors, Opioid, muOligopeptidesCardiotonic AgentsCreatine Kinase

Autor:innen und Institutionen

  • Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russia.
  • Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russia. sasha_m91@mail.ru.
  • Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Pushchino, Russia.

Zitieren

APA

Gorbunov, A. S., Mukhomedzyanov, A. V., Popov, S. V., Azev, V. N., & Maslov, L. N. (2024). Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro. Bulletin of Experimental Biology and Medicine, 178(1), 86-90. https://doi.org/10.1007/s10517-024-06287-6

Vancouver

Gorbunov AS, Mukhomedzyanov AV, Popov SV, Azev VN, Maslov LN. Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro. Bulletin of Experimental Biology and Medicine. 2024;178(1):86-90. doi:10.1007/s10517-024-06287-6

BibTeX
@article{Gorbunov2024,
  author = {Gorbunov, A S and Mukhomedzyanov, A V and Popov, S V and Azev, V N and Maslov, L N},
  title = {Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro},
  journal = {Bulletin of Experimental Biology and Medicine},
  year = {2024},
  volume = {178},
  number = {1},
  pages = {86--90},
  doi = {10.1007/s10517-024-06287-6}
}
Kostenlos starten →